Companies / eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.
EFTRLWACCIK 1828522
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 25, 2021 | Root Jonathan D Director | Grant Grant or award | Common Stock | $6.91M | +691K +17.35% | 4,672,628 | low |
| Aug 25, 2021 | Worland Stephen T CEO | Grant Grant or award | Common Stock | $500.0K | +50K +9.76% | 562,339 | low |
| Nov 10, 2021 | Casey M Tansey 10% owner | Sell Open-market sale | Common Stock | $343.8K | -33K -0.71% | 4,611,790 | medium |
| Nov 10, 2021 | Root Jonathan D Director | Sell Open-market sale | Common Stock | $343.8K | -33K -0.71% | 4,611,790 | medium |
| Nov 9, 2021 | Casey M Tansey 10% owner | Sell Open-market sale | Common Stock | $306.9K | -28K -0.60% | 4,644,736 | medium |
| Nov 9, 2021 | Root Jonathan D Director | Sell Open-market sale | Common Stock | $306.9K | -28K -0.60% | 4,644,736 | medium |
| Nov 27, 2023 | SR One Capital Management, LLC 10% owner | Sell Open-market sale | Common Stock | $261.1K | -431K -8.93% | 4,391,536 | medium |
| Nov 24, 2021 | Casey M Tansey 10% owner | Sell Open-market sale | Common Stock | $260.3K | -35K -0.79% | 4,467,204 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EFTR | common | 28202V207 |